Archive - September 2020
EU expands scope of Imbruvica to include untreated CLL patients
AbbVie signs immunotherapy pact with I-Mab worth $2bn
Russia’s COVID-19 vaccine demonstrates early potential in Lancet report
Genentech’s Gavreto cleared for RET non-small cell lung cancer
High-dose Enerzair Breezhaler further cuts asthma exacerbations
Gonorrhoea cases hit highest level since records began
Destiny, SporeGen collaborate on COVID-19 prevention spray
You Can Still Have Fun This Labor Day Weekend – and Stay Safe!